Dushianthan, Ahilanandan
Clark, Howard W.
Brealey, David
Pratt, Danny
Fink, James B.
Madsen, Jens
Moyses, Helen
Matthews, Lewis
Hussell, Tracy
Djukanovic, Ratko
Feelisch, Martin
Postle, Anthony D.
Grocott, Michael P. W.
Funding for this research was provided by:
Bill and Melinda Gates Foundation (INV-016631)
Article History
Received: 22 September 2023
Accepted: 16 November 2023
First Online: 28 November 2023
Competing interests
: Dr Fink is CSO of Aerogen Pharma Corporation and all other authors declare no conflicts of interest.